Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876626 · ClinicalTrials.gov registry record · NA
Using Smart Phone Technology to Support HIV Medication Refill Adherence in Virginia
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03876626: Completed NA study, sponsored by University of Virginia.
NCT03876626 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03876626, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to pilot a mobile health intervention, originally designed for HIV retention in care, for use in aiding patients with medication refills. The study will implement the PositiveLinks Rx app with the Henrico Health department. The study will assess user engagement and satisfaction with the app as well as preliminary impact on patient refill compliance.
Primary Outcome
Primary variable analysis will include examination of patient medication refill compliance at baseline and at the 6-month follow-up to assess for any change in refill compliance.
Interventions
- OTHER PositiveLinks RX Mobile App
- OTHER PositiveLinks RX Portal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-03-21 |
| Est. Completion | 2020-09-21 |
| Phase | NA |
What the finished NCT03876626 record still lists
NCT03876626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which PositiveLinks RX Mobile App is the first listed.
NCT03876626 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03876626 about?
NCT03876626 is a clinical study titled "Using Smart Phone Technology to Support HIV Medication Refill Adherence in Virginia". The purpose of this study is to pilot a mobile health intervention, originally designed for HIV retention in care, for use in aiding patients with medication refills. The study will implement the PositiveLinks Rx app with the Henrico Health department. The study will assess user engagement and satis...
What is the current status of trial NCT03876626?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-03-21. Estimated completion is 2020-09-21.
What interventions are being tested in trial NCT03876626?
The interventions under investigation include: PositiveLinks RX Mobile App (OTHER), PositiveLinks RX Portal (OTHER).
Who is sponsoring clinical trial NCT03876626?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03876626's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI